SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Genome-based Drug Discovery

PUBLISHER: Grand View Research | PRODUCT CODE: 2152748

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2152748

Mutational Analysis Market Size, Share & Trends Analysis Report By Mutation Type, By Technology, By Product & Service, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Mutational Analysis Market Summary

The global mutational analysis market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.4 billion in 2026 to USD 7.5 billion by 2033, at a CAGR of 17.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 42.8% in 2025. The market growth is driven by increasing adoption of next-generation sequencing and molecular profiling technologies, growing demand for precision medicine, and expanding applications of mutational analysis in cancer genomics, inherited disease diagnosis, and drug development.

Global Mutational Analysis Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global mutational analysis market on the basis of mutation type, technology, product & service, end use, and region.

  • Mutation Type Outlook (Revenue, USD Million, 2021-2033)
  • SNVs/Point Mutations
  • Indels
  • Copy Number Variants
  • Structural Variants
  • Repeat Expansions
  • Other Mutations
  • Technology Outlook (Revenue, USD Million, 2021-2033)
  • Sequencing-based
  • PCR-based
  • Microarray-based
  • CRISPR-based
  • Other Molecular Methods
  • Product & Service Outlook (Revenue, USD Million, 2021-2033)
  • Instruments & Equipment
  • Consumables & Reagents
  • Software & Bioinformatics
  • Testing & Analytical Services
  • End Use Outlook (Revenue, USD Million, 2021-2033)
  • Clinical & Diagnostics
  • Precision Medicine
  • Research & Drug Development
  • Academic/CRO Research
  • Others
  • Regional Outlook (Revenue, USD Million, 2021-2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68041-039-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Mutation Type Segment
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Product & Service Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
    • 1.9.2. List of Secondary Sources
    • 1.9.3. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing Demand for Comprehensive Detection of Genomic Mutations
      • 3.2.1.2. Rising Adoption of Mutation Analysis in Precision Oncology and Targeted Therapy
      • 3.2.1.3. Advancements in Sequencing Technologies for Mutation Detection
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Costs and Uneven Reimbursement for Mutation and Genomic Testing
      • 3.2.2.2. Technical Limitations in Detecting Complex and Low-Frequency Mutations
    • 3.2.3. Market Opportunities Analysis
    • 3.2.4. Market Challenges Analysis
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Economic landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. Mutation Type Business Analysis

  • 4.1. Segment Dashboard
  • 4.2. Mutational Analysis Market: Mutation Type Movement Analysis
  • 4.3. SNVs/Point Mutations
    • 4.3.1. SNVs/Point Mutations Market, 2021-2033 (USD Million)
  • 4.4. Indels
    • 4.4.1. Indels Market, 2021-2033 (USD Million)
  • 4.5. Copy Number Variants
    • 4.5.1. Copy Number Variants Market, 2021-2033 (USD Million)
  • 4.6. Structural Variants
    • 4.6.1. Structural Variants Market, 2021-2033 (USD Million)
  • 4.7. Repeat Expansions
    • 4.7.1. Repeat Expansions Market, 2021-2033 (USD Million)
  • 4.8. Other Mutations
    • 4.8.1. Other Mutations Market, 2021-2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Segment Dashboard
  • 5.2. Mutational Analysis Market: Technology Movement Analysis
  • 5.3. Sequencing-based
    • 5.3.1. Sequencing-based Market, 2021-2033 (USD Million)
  • 5.4. PCR-based
    • 5.4.1. PCR-based Market, 2021-2033 (USD Million)
  • 5.5. Microarray-based
    • 5.5.1. Microarray-based Market, 2021-2033 (USD Million)
  • 5.6. CRISPR-based
    • 5.6.1. CRISPR-based Market, 2021-2033 (USD Million)
  • 5.7. Other Molecular Methods
    • 5.7.1. Other Molecular Methods Market, 2021-2033 (USD Million)

Chapter 6. Product & Service Business Analysis

  • 6.1. Segment Dashboard
  • 6.2. Mutational Analysis Market: Product & Service Movement Analysis
  • 6.3. Instruments & Equipment
    • 6.3.1. Instruments & Equipment Market, 2021-2033 (USD Million)
  • 6.4. Consumables & Reagents
    • 6.4.1. Consumables & Reagents Market, 2021-2033 (USD Million)
  • 6.5. Software & Bioinformatics
    • 6.5.1. Software & Bioinformatics Market, 2021-2033 (USD Million)
  • 6.6. Testing & Analytical Services
    • 6.6.1. Testing & Analytical Services Market, 2021-2033 (USD Million) \

Chapter 7. End Use Business Analysis

  • 7.1. Segment Dashboard
  • 7.2. Mutational Analysis Market: End Use Movement Analysis
  • 7.3. Clinical & Diagnostics
    • 7.3.1. Clinical & Diagnostics Market, 2021-2033 (USD Million)
  • 7.4. Precision Medicine
    • 7.4.1. Precision Medicine Market, 2021-2033 (USD Million)
  • 7.5. Research & Drug Development
    • 7.5.1. Research & Drug Development Market, 2021-2033 (USD Million)
  • 7.6. Academic/CRO Research
    • 7.6.1. Academic/CRO Research Market, 2021-2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Others Market, 2021-2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Mutational Analysis Market Share By Region, 2025 & 2033
  • 8.2. North America
    • 8.2.1. North America Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. U.S. Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Canada Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Competitive Scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Mexico Mutational Analysis Market, 2021-2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. UK Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Germany Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. France Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Italy Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Spain Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Denmark Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Sweden Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Norway Mutational Analysis Market, 2021-2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Japan Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. China Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. India Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Australia Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Thailand Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. South Korea Mutational Analysis Market, 2021-2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Brazil Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Argentina Mutational Analysis Market, 2021-2033 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. South Africa Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Saudi Arabia Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. UAE Mutational Analysis Market, 2021-2033 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Kuwait Mutational Analysis Market, 2021-2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Company Market Share/ Position Analysis, 2025
  • 9.3. Strategy Mapping
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Type Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Illumina, Inc
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Type Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. F. Hoffmann-La Roche Ltd
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Type Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. QIAGEN
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Type Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Agilent Technologies, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Type Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Bio-Rad Laboratories, Inc.
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Type Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Oxford Nanopore Technologies plc.
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Type Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. PacBio
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Type Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Takara Bio Inc.
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Type Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Revvity
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Type Benchmarking
      • 9.4.10.4. Strategic Initiatives
      • 9.4.10.5. Overview
      • 9.4.10.6. Financial Performance
      • 9.4.10.7. Product Type Benchmarking
      • 9.4.10.8. Strategic Initiatives
Show more
Product Code: GVR-4-68041-039-3

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 4 Global mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 5 Global mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 6 Global mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 7 Global mutational analysis market, by region, 2021-2033 (USD million)
  • Table 8 North America mutational analysis market, by country, 2021-2033 (USD million)
  • Table 9 North America mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 10 North America mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 11 North America mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 12 North America mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 13 U.S. mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 14 U.S. mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 15 U.S. mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 16 U.S. mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 17 Canada mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 18 Canada mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 19 Canada mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 20 Canada mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 21 Mexico mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 22 Mexico mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 23 Mexico mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 24 Mexico mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 25 Europe mutational analysis market, by country, 2021-2033 (USD million)
  • Table 26 Europe mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 27 Europe mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 28 Europe mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 29 Europe mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 30 UK mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 31 UK mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 32 UK mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 33 UK mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 34 Germany mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 35 Germany mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 36 Germany mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 37 Germany mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 38 France mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 39 France mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 40 France mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 41 France mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 42 Italy mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 43 Italy mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 44 Italy mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 45 Italy mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 46 Spain mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 47 Spain mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 48 Spain mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 49 Spain mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 50 Denmark mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 51 Denmark mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 52 Denmark mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 53 Denmark mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 54 Sweden mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 55 Sweden mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 56 Sweden mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 57 Sweden mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 58 Norway mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 59 Norway mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 60 Norway mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 61 Norway mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 62 Asia Pacific mutational analysis market, by country, 2021-2033 (USD million)
  • Table 63 Asia Pacific mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 64 Asia Pacific mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 65 Asia Pacific mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 66 Asia Pacific mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 67 Japan mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 68 Japan mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 69 Japan mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 70 Japan mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 71 China mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 72 China mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 73 China mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 74 China mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 75 India mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 76 India mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 77 India mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 78 India mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 79 Australia mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 80 Australia mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 81 Australia mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 82 Australia mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 83 Thailand mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 84 Thailand mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 85 Thailand mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 86 Thailand mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 87 South Korea mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 88 South Korea mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 89 South Korea mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 90 South Korea mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 91 Latin America mutational analysis market, by country, 2021-2033 (USD million)
  • Table 92 Latin America mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 93 Latin America mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 94 Latin America mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 95 Latin America mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 96 Brazil mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 97 Brazil mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 98 Brazil mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 99 Brazil mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 100 Argentina mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 101 Argentina mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 102 Argentina mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 103 Argentina mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 104 Middle East & Africa mutational analysis market, by country, 2021-2033 (USD million)
  • Table 105 Middle East & Africa mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 106 Middle East & Africa mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 107 Middle East & Africa mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 108 Middle East & Africa mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 109 South Africa mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 110 South Africa mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 111 South Africa mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 112 South Africa mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 113 Saudi Arabia mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 114 Saudi Arabia mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 115 Saudi Arabia mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 116 Saudi Arabia mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 117 UAE mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 118 UAE mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 119 UAE mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 120 UAE mutational analysis market, by end use, 2021-2033 (USD million)
  • Table 121 Kuwait mutational analysis market, by mutation type, 2021-2033 (USD million)
  • Table 122 Kuwait mutational analysis market, by technology, 2021-2033 (USD million)
  • Table 123 Kuwait mutational analysis market, by product & service, 2021-2033 (USD million)
  • Table 124 Kuwait mutational analysis market, by end use, 2021-2033 (USD million)

List of Figures

  • Fig. 1 Mutational analysis market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market outlook
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Mutational analysis market driver analysis
  • Fig. 12 Mutational analysis market restraint analysis
  • Fig. 13 Mutational analysis market: Porter's five forces analysis
  • Fig. 14 Mutational analysis market: PESTLE analysis
  • Fig. 15 Mutational analysis market: mutation type outlook and key takeaways
  • Fig. 16 Mutational analysis market: mutation type market share analysis
  • Fig. 17 SNVs/point mutations market, 2021-2033 (USD million)
  • Fig. 18 Indels market, 2021-2033 (USD million)
  • Fig. 19 Copy number variants market, 2021-2033 (USD million)
  • Fig. 20 Structural variants market, 2021-2033 (USD million)
  • Fig. 21 Repeat expansions market, 2021-2033 (USD million)
  • Fig. 22 Other mutations market, 2021-2033 (USD million)
  • Fig. 23 Mutational analysis market: technology outlook and key takeaways
  • Fig. 24 Mutational analysis market: technology market share analysis
  • Fig. 25 Sequencing-based market, 2021-2033 (USD million)
  • Fig. 26 PCR-based market, 2021-2033 (USD million)
  • Fig. 27 Microarray-based market, 2021-2033 (USD million)
  • Fig. 28 CRISPR-based market, 2021-2033 (USD million)
  • Fig. 29 Other molecular methods market, 2021-2033 (USD million)
  • Fig. 30 Mutational analysis market: product & service outlook and key takeaways
  • Fig. 31 Mutational analysis market: product & service market share analysis
  • Fig. 32 Instruments & equipment market, 2021-2033 (USD million)
  • Fig. 33 Consumables & reagents market, 2021-2033 (USD million)
  • Fig. 34 Software & bioinformatics market, 2021-2033 (USD million)
  • Fig. 35 Testing & analytical services market, 2021-2033 (USD million)
  • Fig. 36 Mutational analysis market: end use outlook and key takeaways
  • Fig. 37 Mutational analysis market: end use market share analysis
  • Fig. 38 Clinical & diagnostics market, 2021-2033 (USD million)
  • Fig. 39 Precision medicine market, 2021-2033 (USD million)
  • Fig. 40 Research & drug development market, 2021-2033 (USD million)
  • Fig. 41 Academic/CRO research market, 2021-2033 (USD million)
  • Fig. 42 Others market, 2021-2033 (USD million)
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 North America mutational analysis market, by country, 2021-2033 (USD million)
  • Fig. 45 U.S. mutational analysis market, 2021-2033 (USD million)
  • Fig. 46 Canada mutational analysis market, 2021-2033 (USD million)
  • Fig. 47 Mexico mutational analysis market, 2021-2033 (USD million)
  • Fig. 48 Europe mutational analysis market, by country, 2021-2033 (USD million)
  • Fig. 49 UK mutational analysis market, 2021-2033 (USD million)
  • Fig. 50 Germany mutational analysis market, 2021-2033 (USD million)
  • Fig. 51 France mutational analysis market, 2021-2033 (USD million)
  • Fig. 52 Italy mutational analysis market, 2021-2033 (USD million)
  • Fig. 53 Spain mutational analysis market, 2021-2033 (USD million)
  • Fig. 54 Denmark mutational analysis market, 2021-2033 (USD million)
  • Fig. 55 Sweden mutational analysis market, 2021-2033 (USD million)
  • Fig. 56 Norway mutational analysis market, 2021-2033 (USD million)
  • Fig. 57 Asia Pacific mutational analysis market, by country, 2021-2033 (USD million)
  • Fig. 58 Japan mutational analysis market, 2021-2033 (USD million)
  • Fig. 59 China mutational analysis market, 2021-2033 (USD million)
  • Fig. 60 India mutational analysis market, 2021-2033 (USD million)
  • Fig. 61 Australia mutational analysis market, 2021-2033 (USD million)
  • Fig. 62 Thailand mutational analysis market, 2021-2033 (USD million)
  • Fig. 63 South Korea mutational analysis market, 2021-2033 (USD million)
  • Fig. 64 Latin America mutational analysis market, by country, 2021-2033 (USD million)
  • Fig. 65 Brazil mutational analysis market, 2021-2033 (USD million)
  • Fig. 66 Argentina mutational analysis market, 2021-2033 (USD million)
  • Fig. 67 MEA mutational analysis market, by country, 2021-2033 (USD million)
  • Fig. 68 South Africa mutational analysis market, 2021-2033 (USD million)
  • Fig. 69 Saudi Arabia mutational analysis market, 2021-2033 (USD million)
  • Fig. 70 UAE mutational analysis market, 2021-2033 (USD million)
  • Fig. 71 Kuwait mutational analysis market, 2021-2033 (USD million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!